Data / Drug companies / Phenobarbital
Phenobarbital: 25 companies and 153 products in the FDA NDC directory
Phenobarbital is listed in the FDA National Drug Code Directory by 25 companies, with 153 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; liquid; elixir, and the newest product started marketing on August 17, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 25
- Products
- 153
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 0
- Controlled substance schedule
- Schedule IV
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list phenobarbital
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Westminster Pharmaceuticals, LLC | 18 | tablet; liquid | Other unapproved drugs | March 6, 2026 |
| Chartwell RX, LLC | 17 | tablet; solution | Other unapproved drugs | August 17, 2026 |
| Proficient Rx LP | 12 | tablet | Other unapproved drugs | November 1, 2020 |
| Rising Pharma Holdings, Inc. | 9 | tablet; liquid | Other unapproved drugs | November 1, 2020 |
| Trigen Laboratories, LLC | 9 | tablet; elixir | Other unapproved drugs | May 5, 2025 |
| Genus Lifesciences | 8 | tablet | Other unapproved drugs | March 1, 2025 |
| Proficient Rx LP | 8 | tablet | Other unapproved drugs | September 8, 2023 |
| Quagen Pharmaceuticals LLC | 8 | tablet | Other unapproved drugs | September 30, 2020 |
| Sun Pharmaceutical Industries, Inc. | 8 | tablet | Other unapproved drugs | August 1, 2024 |
| Winder Laboratories LLC | 8 | tablet | Other unapproved drugs | June 11, 2019 |
| Bryant Ranch Prepack | 7 | tablet; liquid | Other unapproved drugs | November 1, 2020 |
| Bryant Ranch Prepack | 7 | tablet; liquid | Other unapproved drugs | November 1, 2020 |
| Clinical Solutions Wholesale, LLC | 6 | tablet | Other unapproved drugs | March 1, 2025 |
| Remedyrepack Inc. | 6 | tablet | Other unapproved drugs | August 3, 2026 |
| Coupler LLC | 4 | tablet | Other unapproved drugs | June 22, 2026 |
| Hikma Pharmaceuticals USA Inc. | 4 | tablet | Other unapproved drugs | March 5, 2020 |
| Par Health USA, LLC | 4 | tablet | Other unapproved drugs | February 1, 2003 |
| E5 Pharma, LLC | 3 | tablet | Other unapproved drugs | November 30, 2022 |
| American Health Packaging | 1 | elixir | Other unapproved drugs | December 19, 2022 |
| Chartwell Governmental & Specialty RX, LLC. | 1 | solution | Other unapproved drugs | February 13, 2025 |
| Eci Pharmaceuticals LLC | 1 | tablet | Other unapproved drugs | March 1, 2020 |
| Major Pharmaceuticals | 1 | tablet | Other unapproved drugs | February 1, 2003 |
| Proficient Rx LP | 1 | tablet | Other unapproved drugs | February 1, 2003 |
| Redpharm Drug | 1 | tablet | Other unapproved drugs | September 8, 2023 |
| Strides Pharma Science Limited | 1 | elixir | Other unapproved drugs | April 4, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 143 | 93.5% |
| Liquid | 4 | 2.6% |
| Elixir | 4 | 2.6% |
| Solution | 2 | 1.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Other unapproved drugs | 153 | 100% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.